| Identification | Back Directory | [Name]
1,8-Diazaspiro[5.5]undecane, 8-[3-(4-pyrimidinyl)-1H-pyrrolo[2,3-b]pyridin-4-yl]-, (6R)- | [CAS]
2284549-25-1 | [Synonyms]
(R)-BDP9066
1,8-Diazaspiro[5.5]undecane, 8-[3-(4-pyrimidinyl)-1H-pyrrolo[2,3-b]pyridin-4-yl]-, (6R)- | [Molecular Formula]
C20H24N6 | [MOL File]
2284549-25-1.mol | [Molecular Weight]
348.44 |
| Chemical Properties | Back Directory | [density ]
1.31±0.1 g/cm3(Predicted) | [storage temp. ]
Store at -20°C | [form ]
Solid | [pka]
14.46±0.40(Predicted) | [color ]
Off-white to light yellow |
| Hazard Information | Back Directory | [Uses]
(R)-BDP9066 is a potent inhibitor of myotonic dystrophy kinase-related Cdc42-binding kinase (MRCK). (R)-BDP9066 blocks cancer cell invasion. (R)-BDP9066 has the potential for the research of proliferative diseases, such as cancer. | [Biological Activity]
(R)-BDP9066 is a potent inhibitor of myotonic dystrophy kinase-related Cdc42-binding kinase (MRCK). (R)-BDP9066 blocks cancer cell invasion. (R)-BDP9066 has the potential for the research of proliferative diseases, such as cancer. | [storage]
Store at -20°C | [References]
[1]. Pyrrolo[2,3-b]pyridine compounds and their use in the treatment of cancer. Patent WO2019034890A1. |
|
|